Risk of metabolic syndrome in the first degree relatives of women with polycystic ovarian syndrome

Authors

  • Yashwant A. M. Assistant Professor, Department of Community Medicine, Malla Reddy Institute of Medical Sciences, Suraram, Telangana
  • Prashant R. Kokiwar Professor & HOD, Department of Community Medicine, Malla Reddy Institute of Medical Sciences, Suraram, Telangana
  • Gazala Taiseen MBBS final year student, Malla Reddy Institute of Medical Sciences, Suraram, Telangana

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20150912

Keywords:

Metabolic syndrome, Polycystic ovarian syndrome, Disorder, Obesity

Abstract

Background: Poly cystic ovarian syndrome (PCOS) is a common disorder, affecting approximately 4 – 8% of women in the reproductive age group. First degree relatives (FDRs) of women with PCOS are at high risk developing endocrine and metabolic co-morbidities of PCOS such as obesity, insulin resistance (IR), and impaired insulin sensitivity, hyperlipidemia and metabolic syndrome (MBS). Present study was conducted with the objectives to evaluate the risk of metabolic syndrome in FDRs of women with PCOS and to compare the risk of metabolic syndrome in FDRs of women with PCOS with age, sex and relation matched FDRs of women with no PCOS. To give suitable recommendations based on the findings of the study.

Methods:Hospital based cross sectional analytical study was carried out. 50 FDRs of women with PCOS were compared against same number of age, sex and relation matched FDRs of women with no PCOS.

Results: The prevalence of MBS was significantly higher i.e. 34% among FDRsPCOS compared to FDRsControls (8%) (p < 0.05). The FDRsPCOS were 5.92 times more at risk of MBS than FDRsControls (p < 0.05). Relation wise it was found that the fatherPCOS and motherPCOS were 1.5 times at risk, brotherPCOS were 14.26 and sisterPCOS were 12.43 times at risk of MBS than their counterparts.

Conclusions:Thus it is concluded that the FDRsPCOS are at high risk of MBS than FDRsControls.

References

Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J ClinEndocrinolMetab. 2009;88(5):2031-6.

Akbarzadeh M, Moradi F, Dabbaghmanesh MH, Jafari P, Parsanezhad ME. A survey of metabolic syndrome in first degree relaties (fathers) of patients with polycystic ovarian syndrome. J EndocrinolMetab and Diabetes of South Africa. 2013;18(2):98-103.

Recabarren SE, Smith R, Rios R, Maliqueo M, Echiburu B, Codner E et al. Metabolic profile in sons of women with polycystic ovary syndrome (PCOS). J ClinEndocrinolMetab. 2008;93(5):1820-6.

Raissouni N, Kolesnikov A, Purushothaman R, Sinha S, Bhandari S, Bhangool A et al. Altered glucose disposition and insulin sensitivity in peri-pubertal first degree relatives of women with polycystic ovary syndrome. Int J PediatrEndocrinol. 2012;2012(1):14.

Sam S, Coviello AD, Sung Ya, Legro RS, Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008;31(6):1237-41.

Pankow JS, Jacobs DR, Steinberger J. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care. 2004;27:775-80.

World Health Organization: Physical status: The use and interpretation of anthropometry: WHO Tech Rep Series. 1995;854:424-38

Park K. Park’s Textbook of Preventive and Social Medicine. 21st edition, M/s BanarasidasBhanot Publishers, Jabalpur, 2005.

Kimberly MM, Leary ET, Cole TG, Waymack PP. Selection, Validation, Standardization, and Performance of a Designated Comparison Method for HDL-Cholesterol for Use in the Cholesterol Reference Method Laboratory Network. Clinical Chemistry. 1999;45:1803-12.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.

Shabir I, Ganie MA, Zargar MA, Bhat D, Mir MM, Jan A, et al. Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India. Indian J EndocrinolMetab. 2014;18(3):364–9.

Coviello AD, Sam S, Legro RS, Dunaif A. High prevalence of Metabolic syndrome in first-degree male relatives of women with Polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinal Metab. 2009;94:4361-6.

Gabrielli L, AquinoEstela ML. Polycystic ovary syndrome in Salvador, Brazil:a prevalence study in primary healthcare.Reproductive Biology and Endocrinology2012;10:96. Available at: http://www.rbej.com/content/10/1/96.

Akbarzadeh M, Moradi F, Dabbaghmanesh MH, Jafari P, Parsanezhad ME. Abnormal blood pressure and hyperandrogenemia in first degree relatives ofwomen with polycystic ovarian syndrome referring to gynecology clinics of Shiraz Medical University. International Journal of Obstetrics and Gyanecology. 2014;2(2):40-4.

Murat Y, Bukan M, ErsoyR, Karakoc A, Yetkin I, Ayvas G et al. Glucose intolerance, insulin resistance and cardiovascular risk factors in firstdegree relatives of women with polycystic ovary syndrome. Human Reproduction. 2005;20(9):2414-20.

Downloads

Published

2017-02-06

How to Cite

M., Y. A., Kokiwar, P. R., & Taiseen, G. (2017). Risk of metabolic syndrome in the first degree relatives of women with polycystic ovarian syndrome. International Journal Of Community Medicine And Public Health, 2(4), 441–448. https://doi.org/10.18203/2394-6040.ijcmph20150912

Issue

Section

Original Research Articles